Ads
related to: novavax stock
Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 16 hours agoNovavax stock nearly tripled over two days in May after inking a roughly $1.3 billion licensing deal...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 22 hours agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
3 Meme Stocks That Are Likely to Crater in 2024
InvestorPlace· 20 hours agoMeme stocks have the potential to completely change the portfolio health even with a limited exposure of 5% to 10%. At the same time, there are meme ...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 5 days agoNovavax (NASDAQ:NVAX) stock has more than doubled today and is up more than 120% at the time of this...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 5 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 4 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 2 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax stock soars 40% on Sanofi partnership
Investing.com· 5 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the $0.92 anticipated by analysts. The company's revenue...